Diverse innate lymphoid cell (ILC) subtypes have been defined on the basis of effector function and transcription factor expression. ILCs derive from common lymphoid progenitors, although the transcriptional pathways that lead to ILC-lineage specification remain poorly characterized. Here we found that the transcriptional regulator TOX was required for the in vivo differentiation of common lymphoid progenitors into ILC lineage-restricted cells. In vitro modeling demonstrated that TOX deficiency resulted in early defects in the survival or proliferation of progenitor cells, as well as ILC differentiation at a later stage. In addition, comparative transcriptome analysis of bone marrow progenitors revealed that TOX-deficient cells failed to upregulate many genes of the ILC program, including genes that are targets of Notch, which indicated that TOX is a key determinant of early specification to the ILC lineage. 
A r t i c l e s
Various types of innate lymphoid cells (ILCs) have been found in mouse and human tissues, including lung, gut, skin and adipose tissue 1 . Despite their lack of antigen receptors, these cells nevertheless display a wide range of effector functions that in many cases mirror those seen in helper T cell subsets. ILCs probably provide a more rapid response to certain pathogens than is provided by the adaptive immune system, as well as serving a role in modulating subsequent innate and adaptive immune responses 1 . In addition, ILCs can have a reparative role in response to tissue injury, wherein cytokine secretion by infected or damaged tissue, rather than foreign antigen production, is the activating signal 2 .
Like helper T cell subsets, subsets of ILCs are classified on the basis of their effector-cytokine-secretion profile, and the development of each subset is associated with key transcriptional regulators. The transcription factor T-bet-dependent cells of ILC group 1 (ILC1) are responsive to interleukin 12 (IL-12), secrete interferon-γ and tumor-necrosis factor, and are involved in controlling intracellular infections 3 . Cells of ILC group 2 (ILC2) secrete IL-5 and IL-13 upon stimulation with IL-33 and, like the T H 2 subset of helper T cells, are dependent on the transcription factor GATA-3 (ref. 4) . However, GATA-3 also has an obligatory role in the development of other ILC lineages 5 . In addition, ILC2 development is dependent on the transcriptional regulators RORα and TCF-1 (refs. 6,7) . The activation of ILC2 cells can in turn regulate eosinophils 8 and alternatively activated macrophages 9 , as well as T H 2 cells, in the context of allergen-induced airway inflammation 10 . Cells of ILC group 3 (ILC3) are dependent on the transcription factor RORγt and include fetal lymphoid tissueinducer cells (LTi cells), which are required for lymph node organogenesis 11 , as well as CD4 + LTi-like cells found in the adult 12 . Other ILC3 cells express the natural cytotoxicity receptor NKp46 (ref. 13) , are dependent on the transcription factor TCF-1 for development 14 and are involved in maintaining intestinal homeostasis 15 . ILC3 cells secrete IL-22 and IL-17A when activated with IL-23 (ref. 16) and secrete granulocyte-macrophage colony-stimulating factor in response to IL-1β produced by macrophages 15 . Splenic ILC3 cells have been identified in both humans and mice and provide help to marginal zone B cells through T cell-independent mechanisms 17 .
All ILCs arise from common lymphoid progenitors (CLPs) in the bone marrow (BM) and fetal liver through a process dependent on receptors of the Notch family 6, [18] [19] [20] and the transcription inhibitor Id2 (refs. 21,22) . PLZF, a transcriptional regulator also linked to the function of natural killer T cells (NKT cells) 23 , marks a subset of ILC lineage-specific progenitor cells. These cells express the integrin α 4 β 7 and can give rise to all ILCs, except LTi cells and conventional natural killer cells (cNK cells) 24 . Such data suggest the presence of an earlier common progenitor of ILCs. Indeed, Id2 reporter mice have been used to identify a cell population called the 'common progenitor to all helperlike ILC' (CHILP) population, which gives rise to multiple ILC lineages, including LTi cells, and includes a subpopulation of PLZF hi cells 3 . Neither the PLZF hi subpopulation nor the CHILP population can differentiate into the cNK cell lineage. The basic leucine zipper transcription factor NFIL3 has been shown to be required for the development A r t i c l e s of cNK cells, ILC1 cells, ILC2 cells and ILC3 cells [25] [26] [27] , and in its absence, the Lin − α 4 β 7 + CD127 + c-Kit lo Sca-1 lo Flt3 − progenitor population, including a minor subset of CXCR6 + cells, fails to develop 27, 28 . However, the relationship between these CXCR6 + cells and the CHILP population is unclear because Id2 was not used as an identifying marker for the former 27 . More restricted precursors of ILC1 cells (ILC1p cells) and ILC2 (ILC2p cells) have also been identified in the BM 4 .
TOX ('thymocyte selection-associated high-mobility group box protein') is a member of the high-mobility group box superfamily of DNA-binding factors 29, 30 and is required for development of various T cell subsets, including CD4 + T cells, regulatory T cells and NKT cells, as well as cNK cells and fetal LTi cells [31] [32] [33] . As a consequence of the loss of LTi cells, TOX-deficient (Tox −/− ) mice lack lymph nodes. On the basis of some phenotypic overlap between Id2 deficiency and TOX deficiency, we investigated whether TOX, like Id2, might also have a broader role in ILC development. Here we found coincident expression of TOX and Id2 in the CHILP population. Moreover, intrinsic TOX deficiency resulted in a low number of ILC1, ILC2 and splenic ILC3 cells, due to inhibition of the development of Lin − α 4 β 7 + CD127 + CD25 − Flt3 − progenitor cells. Wholetranscriptome analysis suggested that loss of TOX led to a post-CLP and pre-CHILP blockade at a potential transitional stage of the development of ILC progenitor cells. Moreover, induction of key ILC transcriptional regulators and cell-survival mediators was diminished in the absence of TOX, and our evidence suggested a failure of full activation of a Notchmediated gene program. In vitro modeling demonstrated an early cellintrinsic defect not only in the proliferation and/or survival of progenitors in the absence of TOX but also in a failure to upregulate various factors key to the development of ILCs. Together our data demonstrate an obligatory role for TOX in the specification of BM progenitors to the ILC lineage.
RESULTS

CHILP cells co-express Tox and Id2
To assess the expression of TOX in the development of ILCs, we generated a TOX reporter mouse strain with insertion of sequence encoding the tandem dimer red fluorescent protein tdTomato in exon 1 of one Tox allele (Tox TOM mice) (Fig. 1a) . As all ILC development is Id2 dependent 21 , we additionally bred Tox TOM mice to Id2 GFP reporter mice, which express green fluorescent protein (GFP) from the Id2 locus 34 . Tox is upregulated during the transition from NK cell precursor (NKp) to immature NK cell in the BM, with subsequent downregulation in splenic mature NK cells (mNK cells) 32 . Expression of TOM in Tox TOM Id2 GFP mice recapitulated that expression pattern, while GFP expression remained high from the immature NK cell stage onward (Fig. 1b) . Together these data led us to assess TOM reporter expression more broadly in additional ILC lineages and progenitor populations.
Adult ILC subsets develop from CLPs 6, 19, 28 (cell population definitions, Supplementary Table 1) . There was little reporter expression in Tox TOM Id2 GFP CLPs (Fig. 1c) . Among Lin − α 4 β 7 + CD127 + CD25 − cells, ~80% were GFP + (Fig. 1d) , which fit the phenotypic definition of the CHILP population. These cells were also TOM + (Fig. 1d) . However, a subpopulation of this α 4 β 7 + subset did not express the Tox or Id2 reporters. Lin − α 4 β 7 + CD127 + CD25 + cells, which include ILC2p cells 4 , also expressed GFP and TOM (Fig. 1d) .
Mature lung ILC2 cells (defined as in Supplementary Fig. 1a ) expressed TOM in a heterogeneous pattern ( Fig. 1e and Supplementary Fig. 1b,c) , as well as Tox mRNA (Fig. 1f) . NKT cells (identified as in Supplementary Fig. 1d ) also expressed TOM (Supplementary Fig. 1b) , consistent with the known role of TOX in NKT cell development 31 , although with a pattern of reporter expression different from that of ILC2 cells (Supplementary Fig. 1b) . Unlike Gata3, which is expressed by ILC2 cells and T H 2 cells 4, 35 , Tox was expressed solely in ILC2 cells (Fig. 1f) . Neither Gata3 nor Tox was expressed by B cells (Fig. 1f) , as expected 31 .
The small intestine lamina propria (LP) contains multiple ILC subsets 1 . All ILC subtypes in the LP expressed TOM (Fig. 1g,h ). ILC3 cells are also present in spleen 17 , and all splenic ILC3 populations contained cells that expressed TOM (Fig. 1i,j) . Together with published results 32 , these data confirmed expression of Tox in all known ILC subsets.
The development of common ILC progenitor cells requires TOX Tox −/− mice had normal numbers of CLPs, compared with that of their wild-type littermates (Fig. 2a-c) . In contrast, there was a substantial loss of Lin − α 4 β 7 + CD127 + Flt3 − cells in the absence of TOX ( Supplementary  Fig. 2a-c) . In wild-type mice, a majority of Lin − α 4 β 7 + CD127 + cells expressed cytokine receptor CD25, and these cells were largely absent from Tox −/− mice (Fig. 2e) . Strikingly, in Tox −/− mice, the number of Lin − α 4 β 7 + CD127 + CD25 − cells, the majority of which were CHILP cells 3, 28 (Fig. 1d) , was reduced to approximately 20% that of their wild-type counterparts (Fig. 2d-f) . A heterogeneous population of Lin − CD45 + NK1.1 + NKp46 + cells consisting of cNK cells (CD27 − CD127 − ), ILC1 cells (CD27 + CD127 + ), ILC3 cells (CD27 − CD127 + ) and ILC1-restricted progenitor cells (ILC1p cells) can be found in the BM 3 . In the absence of TOX, this cell population was lost ( Fig. 2g-i) .
ILC2 cells develop from CLPs through an ILC2 lineage-committed progenitor cell (the ILC2p cell) 4 . ILC2p cells also expressed TOM (Fig. 1d) and were absent from Tox −/− BM ( Fig. 2j-l) . ILC2p cells are IL-33R + , and this population can be expanded in vivo upon injection of IL-33 (ref. 4) . Intraperitoneal injection of IL-33 led to a modest increase in the number of ILC2p cells in the BM of Tox −/− mice, but not to the frequency seen in wild-type mice ( Supplementary Fig. 2d-f) .
Given the TOX-dependent development of ILC-committed progenitors, we predicted a failure in the development of mature ILCs in Tox −/− mice. Both cNK cells and ILC1 cells were present in lungs of wild-type mice but not in those of Tox −/− mice ( Fig. 3a-d) . NK1.1 + NKp46 + cells were lost from Tox −/− mice in the colon (Fig. 3e,f) and small intestine (Fig. 3g,h ). Intracellular staining of lineage-determining transcription factors in the colon (Supplementary Fig. 3a ) and small intestine ( Supplementary Fig. 3b ) indicated that these cells consisted of cNK cells and ILC1 cells, as well as a minor population of ILC3 cells.
Tox −/− lungs had significantly fewer ILC2 cells than wild-type lungs had (Fig. 3i-k) . As is also true for T cell development 33 , heterozygous loss of Tox (Tox +/− ) had no effect on the abundance of ILC2 cells (Fig. 3j,k) . ILC2 populations expanded considerably in the lungs of IL-33-treated wild-type mice (Fig. 3l-n) . However, we observed only a minimal change in the frequency and number of ILC2 cells in the lungs of IL-33-treated Tox −/− mice compared with that in untreated Tox −/− mice ( Fig. 3l-n) . The expanded ILC2 cell population from Tox −/− mice also had lower expression of the ST2 subunit of the receptor IL-33R than did wild-type ILC2 cells (Fig. 3o) , possibly indicative of abnormal development.
Splenic ILC3 cells included both CD4 − and CD4 + populations, and both were significantly smaller in Tox −/− mice than in wild-type mice (Fig. 3p-r) . Similarly, splenic NKp46 + ILC3 cells (P < 0.01) and NKp46 − ILC3 cells (P < 0.05) were significantly less abundant in the absence of TOX than in its presence ( Supplementary Fig. 4a,b) . ILC3 cells in the LP are heterogeneous, containing fetus-derived LTi-like cells and post-natal NKp46 − (both T-bet + and T-bet − ) cells and NKp46 + T-bet + cells 36 . Even in mice in which splenic ILC3 cells were lost, there was no reduction in the frequency of total ILC3 cells in Tox −/− LP or in subpopulations defined by their expression of NKp46 or T-bet, relative to their abundance in wild-type LP (Supplementary Fig. 4a,b,d,e) . In contrast, ILC2 cells were absent from Tox −/− LP (Supplementary Fig. 4c) . Moreover, the yield of A r t i c l e s NKp46 + ILC3 cells was significantly greater in Tox −/− LP preparations than in their wild-type counterparts (Supplementary Fig. 4e ). We also isolated NKp46 − ILC3 cells in greater numbers from Tox −/− mice than from wild-type mice, although this difference did not reach statistical significance (Supplementary Fig. 4e ). In contrast to its wild-type counterpart, the Tox −/− NKp46 − T-bet − subset did not contain CCR6 hi cells (Supplementary Fig. 4d ), consistent with loss of the fetal LTi-like subpopulation 36 .
Loss of TOX resulted in a nearly complete block in development of CD4 + T cells in the thymus 31 (Supplementary Fig. 4f ). Nevertheless, we observed Lin + CD45 + Thy-1 + CD4 + cells in the LP of Tox −/− mice, and the majority of these were RORγt + (Supplementary Fig. 4f) . Moreover, >80% of the total Lin + CD45 + Thy-1 + cell population in Tox −/− mice was RORγt + (Supplementary Fig. 4f ). This was consistent with an inflammatory environment in the Tox −/− small intestine, potentially caused by a loss of regulatory T cells 31 . Whether TOX-independent lineages of ILC3 cells exist or, alternatively, if the perturbed immune system in Tox −/− mice leads to the expansion of minor populations of both CD4 + T cells and ILC3 cells remains to be determined.
To verify that loss of TOX inhibited ILC development by a cell-intrinsic mechanism, we generated BM chimeras by injecting wild-type and Tox −/− CLPs at equal ratios into NSG mice, which lack all T cells, B cells 
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A r t i c l e s and ILCs. Of the donor-derived Lin − α 4 β 7 + CD127 + progenitor cells that developed, greater than 85% were derived from wild-type CLPs (Fig. 4a) . Similarly, the vast majority of donor-derived ILC1 cells (Fig. 4b ) and ILC2 cells (Fig. 4c ) in the lungs, as well as splenic ILC3 cells (Fig. 4d) , were derived from wild-type CLPs (compiled data, Fig. 4e ). In contrast, we did not observe a wild-type bias during thymocyte development (data not shown). Thus, all subtypes of ILCs, including the common progenitor, were intrinsically TOX dependent.
Transcriptome analysis of Tox −/− ILC progenitors Tox −/− mice had considerably fewer Lin − α 4 β 7 + CD127 + CD25 − Flt3 − BM cells, which include the earliest known ILC progenitors 3, 24 , than wild-type mice had, although they were not entirely absent from Tox −/− mice ( Fig. 2f and Supplementary Fig. 2a-c) . We took advantage of this to define the TOX-dependent stage of precursor development by global transcriptome analysis of the remaining progenitor cells (Fig. 5a,b) . Notably, while wild-type progenitor cells had a range of expression of the cytokine receptor CD127 (IL-7Rα), Tox −/− cells had more uniformly lower expression of CD127 (Fig. 5a) .
Unsupervised hierarchical clustering revealed that coordinated downregulation of many genes was associated with the Tox −/− phenotype (Supplementary Fig. 5 ). This was consistent with a principal role for TOX as a transcriptional activator 37 . 713 well-annotated genes had significantly higher expression (more than twofold higher) in wild-type cells than in Tox −/− cells (q value, <0.05; Supplementary Table 2) .
Consistent with the expression of the TOM reporter (Fig. 1d) , Tox was expressed in wild-type precursor cells and acted as an internal control for Tox −/− cells (Fig. 5b) . The family member Tox2 had more moderate expression in wild-type precursor cells than did Tox, but also exhibited lower expression in Tox −/− cells than in wild-type cells. We were unable to detect Tox3 expression, while expression of Tox4, in general a ubiquitously expressed family member 37 , did not differ between wild-type cells and Tox −/− cells.
Genes encoding lineage markers were expressed poorly if at all, and their expression did not differ between wild-type cells and Tox −/− cells. Itga4 and Itgb7, which encode the marker α 4 β 7 used for cell isolation, were expressed, and their expression did not differ in wild-type cells versus Tox −/− cells (Fig. 5b) . Both cell populations also had equivalent expression of Ptprc (which encodes the marker CD45) and Thy1 (which encodes the marker Thy-1) (Fig. 5b) . Expression of Il7r (which encodes CD127 (IL-7Rα)) was significantly lower in Tox −/− progenitor cells than in their wild-type counterparts (Fig. 5b) , consistent with cellsurface expression of the encoded protein (Fig. 5a) , as was Il2rg (which encodes the common cytokine receptor γ-chain) (Fig. 5b) . Tox −/− cells also failed to express Bcl2 (which encodes the antiapoptotic molecule Bcl-2) in the amounts seen in wild-type cells (Fig. 5b) . Il1rl1 mRNA and IL17rb mRNA, both expressed by mature ILC2 cells, were also markedly decreased in Tox −/− progenitor cells compared with their abundance in wild-type progenitor cells, as was Eomes mRNA (Fig. 5b) . How expression of these genes in wild-type progenitor cells compares with that of mature ILCs, however, is unknown. Thus, low expression could represent the onset of locus accessibility.
Id2 had high expression in the wild-type progenitor population (Fig. 5b) , as expected. While we also detected Id2 expression in (Fig. 5b) . The expression of genes encoding key transcriptional regulators of ILC development, including Gata3, Rora, Rorc, Tcf7 and Zbtb16, was also significantly lower in Tox −/− progenitor cells that in wild-type progenitor cells (Fig. 5b) . In contrast, Gfi1 and Nfil3 did not have different expression in wild-type cells versus Tox −/− cells (Fig. 5b) . The inducible T cell co-stimulator ICOS is expressed early in ILC development, and the gene encoding ICOS is a downstream target of PLZF 38 . ICOS was expressed by approximately 40% of CHILP cells, while nearly all ILC2p cells expressed this cell-surface protein (Fig. 5c) . In the absence of TOX, Icos expression was 98% lower than that in wild-type cells (Fig. 5b) (Fig. 5b) .
A role for retinoic acid in the homeostasis of ILC2 and ILC3 cells as well as the maturation of LTi cells has been reported 39, 40 . Rxrg (which encodes retinoid X receptor-γ) was expressed by wild-type cells, but its expression was undetectable in Tox −/− progenitor cells (Fig. 5b) . 
A r t i c l e s
Genes encoding other isoforms of the retinoid X receptor and retinoic acid receptor were either not expressed differentially in Tox −/− relative to their expression in wild-type cells or were poorly expressed by both cell types. In addition, expression of the chemokine receptor-encoding gene Ccr9, a downstream target of retinoic acid signaling 41 , was significantly lower in Tox −/− progenitor cells than in wild-type cells. Expression of the chemokine receptor CXCR6 identifies a non-CLP, early pan-ILC progenitor population 27, 28 ; Tox −/− progenitor cells had significantly lower Cxcr6 expression than did wild-type progenitor cells. Adult ILCs are dependent on Notch signaling for their development 6, [18] [19] [20] . Consistent with this, the Notch target gene Hes1 (which A r t i c l e s encodes the transcriptional regulator Hes-1) was expressed by wildtype progenitors (Fig. 5b) . Unexpectedly, however, genes encoding members of the Notch family had poor or undetectable expression in these cells (Fig. 5b) . As ILC development may require a transient Notch signal 6, 18 , we considered the possibility that this might be caused by downregulation of expression of the Notch family. To address this, we stained CLPs, α 4 β 7 + progenitor cells and more restricted ILC2p cells for Notch1. Indeed, Notch1 had higher expression in CLPs than in downstream progenitor cells (Fig. 5d) . Tox −/− CLPs expressed Notch1 normally (Fig. 5e) . Despite that finding, Tox −/− α 4 β 7 + progenitor cells failed to upregulate either Hes1 or Tcf7, another gene target of Notch signaling 7 (Fig. 5b) . Together these results indicated that TOX-deficient progenitor cells lacked key ILC transcriptional regulators necessary for their subsequent development.
In vitro ILC differentiation requires TOX High-throughput sequencing technologies for cDNA (RNA-seq analysis) suggested there might be poor survival of ILC progenitors in the absence of TOX, as well as a failure to fully activate genes downstream of Notch signaling (Fig. 5b) . ILC development can be modeled in vitro by culture of BM-derived CLPs with OP9 stromal cells that express the Notch ligand DL1 (OP9-DL1 cells) 6 . We took advantage of this system, which allows analysis of cell numbers as well as cell differentiation, to assess the expression and role of TOX during ILC specification. We cultured CLPs with OP9-DL1 cells (OP9-DL1 cultures) or, as a control, with OP9 cells (which promote B cell development). CLPs from wild-type and Tox −/− mice showed similar CD127 expression (Supplementary Fig. 6a ) and equivalent B cell potential (Supplementary Fig. 6b) .
To assess the induction of Tox, we cultured wild-type or Tox TOM CLPs in OP9-DL1 cultures. As early as 6 d of culture, the differentiation of CLPs resulted in substantial expansion and appearance of Lin − CD25 − Thy-1 lo , Lin − CD25 + Thy-1 lo and Lin − Thy-1 hi cell populations, with progressive upregulation of TOM in these cells (Fig. 6a) . A small subpopulation of Lin − Thy-1 − CD25 − cells remained in culture and did not express TOM; these probably represented undifferentiated CLPs.
To assess the effect of loss of TOX in this system, we compared the differentiation of wild-type and Tox −/− CLPs. Tox −/− CLPs showed significant deficits in population expansion (Fig. 6b) and differentiation (Fig. 6c-e) . We also noted that Lin − Thy-1 hi cells derived from Tox −/− CLPs failed to downregulate CD25 expression (Fig. 6c,f) or upregulate ICOS expression (Fig. 6f) .
We assessed the Lin − Thy-1 lo CD25 + -to-Lin − Thy-1 hi transition for the expression of transcriptional regulators involved in ILC development 4, 6, 7, 21, 24 . Id2, Gata3, Rora, Tcf7 and Zbtb16 were significantly upregulated in wild-type Lin − Thy-1 hi cells relative to their expression in wild-type Lin − Thy-1 lo cells (Fig. 6g) , consistent with developmental progression of these cells to an ILC fate. However, the expression of Id2, Gata3 and Rora in wild-type Lin − Thy-1 hi cells was well below that of mature wild-type ILC2 cells (used as an internal comparison for gene expression). We consistently observed upregulation of Tox in Lin − Thy-1 hi cells relative to its expression in Lin − Thy-1 lo cells in individual experiments, although this result did not reach overall statistical significance. The expression of Rora, Tcf7 and Zbtb16 was significantly lower in Tox −/− To further delineate the potential of TOX-deficient CLPs to develop into ILC lineages, we generated wild-type and Tox −/− Lin − Thy-1 hi cells in vitro and cultured these cells at an equal ratio in OP9-DL1 cultures under ILC-promoting conditions (IL-7 plus the cytokine SCF). These cells differentiated into the ILC1 and ILC2 lineages (Fig. 7a,b) and retained Thy-1 hi expression (data not shown). However, greater than 90% of ILC1 cells and ILC2 cells were derived from wild-type cells (Fig. 7a,c) , despite elimination of the growth and differentiation (i.e., transition to Thy-1 hi ) advantage of wild-type cells. Notably, the NK1.1 − ICOS − cells that remained in these cultures showed no bias toward a wild-type phenotype (Fig. 7a,c) , which indicated a specific defect in differentiation in the absence of TOX, and not solely diminished cell growth or survival.
To assess the role of TOX in the generation of functional ILCs, we maintained OP9-DL1 cultures under ILC2 conditions (IL-7 plus IL-33) and used ICOS as a marker 6 . Tox −/− CLPs were poor generators of Lin − Thy-1 hi cells (Fig. 7d) . Nevertheless, re-plating of equivalent numbers of mutant and wild-type cells at day 6 and then every 6 d onward allowed comparative analysis at day 18. At this time point, a well-defined population of Lin − Thy-1 hi ICOS + CD25 lo−neg cells was present in wild-type cultures (Fig. 7e) . There was significant upregulation of Id2, Gata3, Rora and Zbtb16 in ICOS + cell populations relative to their expression in ICOS − wild-type cell populations, which reached expression equivalent to or exceeding that found in mature ILC2 cells (Fig. 7f) . Nfil3, which encodes a factor required for the normal development of cNK cells 42 and other ILCs [25] [26] [27] 43 , was also significantly upregulated in wild-type Lin − Thy-1 hi ICOS + cells relative to its expression in Lin − Thy-1 hi ICOS − cells (Fig. 7f) . In contrast, neither Tox nor Tcf7 was expressed differentially in ICOS − wild-type cells relative to their expression in ICOS + wild-type cells (Fig. 7f) , consistent with an earlier peak of induction of these genes at day 6 (Fig. 6g) .
In addition to the substantial deficit in the differentiation of mutant CLPs to the Lin − Thy-1 hi stage, few ICOS + CD25 lo−neg Tox −/− cells formed in OP9-DL1 cultures under ILC2 conditions (Fig. 7e,g,h) . Moreover, wild-type cells secreted IL-5 ( Fig. 7i) and IL-13 (Fig. 7j) 
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A r t i c l e s or IL-13 (Fig. 7i,j) , which mirrored the TOX dependence of ILC2 development observed in vivo. ILC progenitors express α 4 β 7 (refs. 3,24) , and we observed initial upregulation of expression of this integrin at day 6 on Thy-1 hi cells (data not shown). At day 18, the majority of wild-type ICOS + cells further upregulated α 4 β 7 expression (Fig. 7k) . In contrast, Tox −/− cultures contained a low frequency of ICOS + cells, and these cells failed to fully upregulate α 4 β 7 expression (Fig. 7k) . PLZF is expressed in α 4 β 7 + ILC progenitors that can give rise to ILC1 cells, ILC2 cells and ILC3 cells and is required for the development of some ILC lineages 24 . Poor upregulation of Zbtb16 (which encodes PLZF) at day 6 (Fig. 6g) , coupled with the inhibition of later development of ICOS + and α 4 β 7 hi cells, led us to investigate whether PLZF expression would also be compromised in the absence of TOX. In wild-type cultures, the majority of ICOS + cells were PLZF hi , with lower PLZF expression in ICOS − cells (Fig. 7l) . In Tox −/− cultures, PLZF hi cells failed to develop, including those in the minor population of Lin − Thy-1 hi ICOS + cells (Fig. 7l) . Therefore, TOX-deficient CLPs failed to develop into ILCs even in the presence of sustained Notch signaling.
DISCUSSION
The identification and characterization of ILCs has led to considerable advances in understanding of the cellular mechanisms that underlie immunological responses during homeostasis and disease. Overlaps in the transcriptional networks that regulate effector T cell subtypes and ILCs have been reported, yet the developmental changes that specifically lead to an ILC fate have not been well established. Here we identified an obligatory role for the transcription factor TOX in the development of ILC1, ILC2 and ILC3 lineages that was due to a block in the transition of CLPs to common ILC progenitors. By wholetranscriptome sequencing and the generation of a TOX reporter, we identified a post-CLP stage of ILC development in which TOX was required. Furthermore, our data offer a window into other potential regulators of the ILC lineage, including various transcriptional regulators not previously linked to ILC development.
The Id2 hi CD25 − subset of α 4 β 7 + progenitors includes CHILP cells, which can give rise to all adult ILCs except cNK cells 3 . All CHILP cells expressed Tox, as assessed by the reporter. A minor subset of CXCR6 + cells within the α 4 β 7 progenitor population has been reported to have the in vivo potential to produce ILC1, ILC2, ILC3 and cNK cells and to be dependent on the transcriptional regulator NFIL3 (ref. 27) . NFIL3 is reported to be required for the induction of TOX in adult mouse BM 27 , although other data suggest a principal role for NFIL3 in regulating Id2 in CHILP cells 43 . Unexpectedly, Tox −/− mice, but not Nfil3 −/− mice, have a complete block in lymph node organogenesis; thus, the exact relationship between TOX and NFIL3 remains to be elucidated. In addition, the relationship between CHILP cells and CXCR6 + progenitors is unclear. CXCR6 + cells might be a small subset of the CHILP population, which would make detection of the cNK cell fate difficult to discern in this mixed population. Alternatively, CXCR6 + cells and CHILP cells may be distinct cell populations, with lower expression of Id2 in the former.
Isolated Tox −/− α 4 β 7 + progenitor cells had lower cell surface expression of CD127 than did the majority of their wild-type counterparts and had lower expression of Il7ra mRNA (which encodes CD127). The transition of fetal liver LTi precursors from RORγt − to RORγt + is associated with upregulation of CD127 expression 44 . In addition, a proportion of isolated wild-type α 4 β 7 + progenitors were CD127 lo . Thus, we propose that Tox −/− α 4 β 7 + progenitors represent a post-CLP but pre-CHILP transitional cell state, with intermediate expression of
Id2 and CD127, and that these cells cannot undergo lineage specification in the absence of TOX.
Like T cells, ILCs are dependent on Notch signaling, with transient Notch signaling favoring the ILC lineage 6 . The expression of Hes1 and Tcf7, which are Notch targets 7 , and of Bcl11b and Gata3, which are potential downstream TCF1 targets 7 , was significantly lower in Tox −/− α 4 β 7 + progenitor cells than in their wild-type counterparts. Downregulation of Notch1 mRNA is also associated with upregulation of CXCR6 expression on α 4 β 7 + progenitor cells 28 . It is possible that downregulation of the expression of genes encoding members of the Notch family during early ILC development ensures transient Notch signaling. Moreover, these data may indicate that one principal deficit in Tox −/− cells might be an inability to activate downstream genes that are targets of Notch signaling. Notably, binding of TOX to the HES1 locus has been detected in HEK293T human embryonic kidney cells 45 .
Maf, which encodes a transcription factor with a critical role in the differentiation of various helper T cell subsets 46 , was poorly expressed by Tox −/− progenitor cells compared with its expression in wild-type cells, and possibly represents an additional example of overlap in the transcriptional landscape of ILC and helper T cell lineages. The expression of Rxrg and the retinoic acid target gene Ccr9 was also significantly lower in the absence of TOX than in its presence, which indicated the potential for modulating ILC development by retinoic acid signaling in ILC progenitor populations, as has been reported for mature ILC subtypes 39, 47 .
The small intestine contains a mix of fetus-derived LTi-like cells that express CCR6 and a heterogeneous mix of post-natal ILCs 36 . Here, the frequency of major populations of ILC3 in the small intestine LP was similar in wild-type mice and Tox −/− mice. Interestingly, other studies have reported substantial populations of LP CD4 − ILC3 cells in Nfil3 −/− mice 43 , despite a block in CHILP cell development similar to that reported here. One possibility is that there is a TOXindependent pathway for the development of gut-resident ILC3 cells. The LP contains CLP-like cells that can give rise to NK cells and RORγt + cells in culture 28 ; thus, the relative contributions of BM progenitors to the development of LP ILC3 cells is not clear. Alternatively, it is possible that the gut microenvironment is particularly conducive to the population expansion of any ILC3 cells that may form, even in small numbers. A proportion of CCR6 − T-bet + ILC3 cells in the LP are proliferative 36 , and in general, ILCs in the small intestine LP have a transcriptome more associated with activated cells than that of ILCs in other locations 47 . The post-natal proliferation of ILC3 cells in the LP could be particularly pronounced in Tox −/− mice, which have a block in the development of CD4 + T cells, including regulatory T cells 31 . In support of the proposal of a disturbed gut microenvironment in these mice, we detected Lin + CD4 + RORγt + cells in Tox −/− mice despite the thymic blockade, as well as a large frequency of other Lin + RORγt + cells. This potential inflammatory environment might influence the homeostasis of ILC3 populations. Definitive molecular delineation of the development of ILC3 cells in the small intestine awaits further experimentation.
On the basis of the data reported above, we propose the following events in the context of the role of TOX in ILC development. Notch signaling in CLPs leads to upregulation of the expression of α 4 β 7 and the early factors TOX and Id2. TOX may be required for the 'translation' of Notch signaling to downstream gene expression, including the induction of Tcf7 and Hes1. Relatively rapid downregulation of genes encoding members of the Notch family at a TOX lo Id2 lo CD127 lo transitional stage might extinguish continued Notch signaling, which would promote an ILC fate rather than a T cell fate. Loss of TOX at this npg early stage would result in a cascading failure in initiating programs of cell survival and differentiation required for continued specification of the ILC lineage through CXCR6 + , CHILP and PLZF hi progenitor stages and, ultimately, failure of commitment to the ILC lineage.
METHODS
Methods and any associated references are available in the online version of the paper.
